424 related articles for article (PubMed ID: 7562909)
1. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
[TBL] [Abstract][Full Text] [Related]
2. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and antitumor activity of amine platinum(II) and (IV) tellurate complexes.
Khokhar AR; Xu Q; Siddik ZH
J Inorg Biochem; 1994 Mar; 53(4):295-301. PubMed ID: 8169608
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
[TBL] [Abstract][Full Text] [Related]
5. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
[TBL] [Abstract][Full Text] [Related]
6. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes.
Kwon YE; Whang KJ; Park YJ; Kim KH
Bioorg Med Chem; 2003 Apr; 11(8):1669-76. PubMed ID: 12659753
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity, antibacterial and antitumor activity of platinum(II) complexes of 3-aminocyclohexanespiro-5-hydantoin.
Kushev D; Gorneva G; Enchev V; Naydenova E; Popova J; Taxirov S; Maneva L; Grancharov K; Spassovska N
J Inorg Biochem; 2002 Apr; 89(3-4):203-11. PubMed ID: 12062124
[TBL] [Abstract][Full Text] [Related]
10. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group.
Shamsuddin S; Takahashi I; Siddik ZH; Khokhar AR
J Inorg Biochem; 1996 Mar; 61(4):291-301. PubMed ID: 8867456
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes.
Khokhar AR; Deng Y; al-Baker S; Yoshida M; Siddik ZH
J Inorg Biochem; 1993 Aug; 51(3):677-87. PubMed ID: 8409984
[TBL] [Abstract][Full Text] [Related]
13. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
Kraker AJ; Hoeschele JD; Elliott WL; Showalter HD; Sercel AD; Farrell NP
J Med Chem; 1992 Nov; 35(24):4526-32. PubMed ID: 1335074
[TBL] [Abstract][Full Text] [Related]
16. Chemical and biological studies on a series of lipid-soluble (trans-(R,R)- and -(S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes.
Khokhar AR; al-Baker S; Brown T; Perez-Soler R
J Med Chem; 1991 Jan; 34(1):325-9. PubMed ID: 1992134
[TBL] [Abstract][Full Text] [Related]
17. Dinuclear alkyldiamine platinum antitumor compounds: a structure-activity relationship study.
Jansen BA; van der Zwan J; den Dulk H; Brouwer J; Reedijk J
J Med Chem; 2001 Jan; 44(2):245-9. PubMed ID: 11170634
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of a series of (aminoethylpyrrolidine) platinum complexes.
Khokhar AR; Brown DB; McCormack JJ; Hacker MP
Cancer Chemother Pharmacol; 1989; 23(1):15-8. PubMed ID: 2909285
[TBL] [Abstract][Full Text] [Related]
19. Bis[platinum(II)] and bis[platinum(IV)] complexes with optically active bis(vicinal-1,2-diamines) and their interaction with DNA.
Büning H; Altman J; Zorbas H; Beck W
J Inorg Biochem; 1999 Jul; 75(4):269-79. PubMed ID: 10499290
[TBL] [Abstract][Full Text] [Related]
20. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
